A novel method for analysis of nuclear receptor function at natural promoters: Peroxisome proliferator-activated receptor γ agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation

Molecular Endocrinology

Volumn 13, Issue 3, 1999, Pages 410-417

  Burris, Thomas P ^a   Pelton, Patricia D ^a   Zhou, Lubing ^a   Osborne, Melville C ^a   Cryan, Ellen ^a   Demarest, Keith T ^a  

^a Drug Discovery Raritan   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

ARTICLE; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; RNA ANALYSIS;

EID: 0032941551     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.3.0246     Document Type: Article

References (25)

1. 1. Schoonjans K, Martin G, Staels B, Auwerx J 1997 Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8:159-166
2. 2. Spiegelman BM 1998 PPARγ: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514
3. 3. Brun RP, Kim JB, Hu E, Spiegelman BM 1997 Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Curr Opin Lipidol 8:212-218
4. 4. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J Biol Chem 270: 12953-12956
5. 5. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM 1996 The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 39:665-668
6. 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812
7. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819
8. 8. Nagy L, Tontonoz P, Alvarez JGA, Chen H, Evans RM 1998 Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93:229-240
9. 9. Tontonoz P, Nagy L, Alvarez JGA, Thomazy VA, Evans RM 1998 PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252
10. 10. Staels B, Auwerx J 1997 Role of PPAR in the pharmacological regulation of lipoprotein metabolism by fibrates and thiazolidinediones. Curr Pharm Res 3:1-14
11. 11. Jiang C, Ting AT, Seed B 1998 PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86
12. 12. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK 1998 The peroxisome proliferator-activated receptor γ is a negative regulator of macrophage activation. Nature 391:79-82
13. 13. Davis GL, Lau JY, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, Albrecht J 1994 Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferontreated patients. Hepatology 19:1337-1341
14. 14. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, Urdea M, Sanchez-Pescador R 1996 Accurate quantification of HCV RNA from all HCV genotypes using branched DNA (bDNA) technology. J Clin Microbiol 34:901-907
15. 15. Hendricks DA, Stowe BS, Hoo BS, Kolberg J, Irvine BS, Neuwald PD, Urdea MS, Perillo RP 1995 Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 104:537-546
16. 16. Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong S-F, Stempien M, Hoo B, Besemer D, Yeghiazarian T, Irvine B, Kolberg J, Kokka R, Neuwald P, Urdea MS 1995 Rapid and precise quantification of HIV-1 RNA in plasma using branched DNA (bDNA) signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 8:446-454
17. 17. Zhou L, Otulakowski G, Lau YC 1997 Use of quantitative PCR as a sensitive method to study retinoid binding protein expression in human skin. Methods Enzymol 282:64-76
18. 18. Zhou L, Ritchie D, Wang EY, Barbone AG, Argentieri D, Lau C 1994 Tepoxalin: a novel immunosuppressive agent with a different mechanism of action from cyclosporin A. J Immunol 151:6166-6174
19. 19. Kazmi SM, Plane RK, Visconti V, Taylor GR, Zhou L, Lau CY 1995 Suppression of NFkB activation and NfkB-dependent gene expression by Tepoxalin, a dual inhibitor of cylooxygenase and 5-lipoxygenase. J Cell Biochem 57:299-310
20. 20. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VKK, O'rahilly S 1997 Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100:3149-3153
21. 21. Gimble JM, Robinson CE, Wu X, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC 1996 Peroxisome proliferator-activated receptor γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 50:1087-1094
22. 22. Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156
23. 23. Kliewer, Umensono K, Noonan DJ, Heyman RA, Evans RA 1992 Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 358:771-774
24. 24. Tontonoz P, Singer S, Forman BM, Sarrag P, Fletcher JA, Fletcher CD, Brun RP, Mueller E, Alotiok S, Oppenheim H, Evans RM, Spiegelman BM 1997 Terminal differenation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor g and the retinoid X receptor. Proc Natl Acad Sci USA 94:237-241
25. 25. Mukherjee R, Davies PJA, Cromble DL, Bischoff ED, Cesario RM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM, Paterniti JR, Heyman RA 1997 Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386:407-410